http://localhost:8080/xmlui/handle/123456789/5852 2026-04-16T02:32:49Z http://localhost:8080/xmlui/handle/123456789/5912 Title: Zero-alcohol beverages and brand extensions: A vehicle for promoting parent alcohol brands? Authors: Bartram, Ashlea; Harrison, Nathan J.; . Norris, Christina A; Christopher, Joanne; Bowden, Jacqueline A. Abstract: Zero-alcohol beverages are beverages that mimic the appearance and taste of alcoholic beverages but contain very low amounts of alcohol. These products are often produced by established alcohol companies under a parent alcohol brand.1 Definitions of zeroalcohol beverages vary from country to country, from <0.05% alcohol by volume in the United Kingdom to <2.8% in Finland, with a threshold of 0.5% being most common.2 In Australia, thresholds of either 0.5% or 1.15% alcohol by volume are used in alcohol policy measures,3 with the former threshold similarly being used to define (non-alcohol) soft drinks under the Food Standards Australia New Zealand Code.4 From 2021 to 2024, the beverage industry forecasts 31% sales growth in zero-alcohol beverages across 10 countries 2024-02-22T00:00:00Z http://localhost:8080/xmlui/handle/123456789/5910 Title: Opportunities for the management of metabolic dysfunction-associated fatty liver disease within Aboriginal and Torres Strait Islander peoples Authors: Dick, Sarah; Wheeler, Kai; . Keating, Shelley E Abstract: Metabolic dysfunction-associated fatty liver disease (MAFLD) is frequently acknowledged as the hepatic manifestation of the metabolic syndrome1 and is characterised by the excessive accumulation of hepatic fat2 within the setting of obesity, type 2 diabetes (T2D) and/or metabolic dysregulation.3 MAFLD is the leading cause of liver disease worldwide,4 with a 20-30% prevalence globally and within Australia.5 MAFLD is strongly linked to both liverspecific morbidity and mortality and extrahepatic morbidity and mortality, notably T2D, cardiovascular disease (CVD) and lifestylerelated cancers.6,7 In Australia, the prevalence of MAFLD is expected to increase by 25% between 2019 and 2030, paralleling trends of increasing obesity and diabetes.8 Concerningly, prevalence is likely underestimated due to the asymptomatic and non-specific nature of the condition in its early stages, lack of awareness and communitylevel screening, and lack of diagnosis until the disease has progressed to later stages.4,9 While the therapeutic landscape for MAFLD management is likely to change with recent advances in Phase III clinical trials,10 there are currently no approved pharmacological agents for the long-term management of MAFLD. Lifestyle therapy is the cornerstone of MAFLD management, with adiposity loss via improved diet quality and increased physical activity/exercise central to MAFLD regression, the prevention of MAFLD progression, and reducing the risk of CVD, T2D and lifestyle-related cancers 2024-02-08T00:00:00Z http://localhost:8080/xmlui/handle/123456789/5902 Title: Peer Health Navigators to improve equity and access to health care in Australia: Can we build on successes from the COVID-19 pandemic? Authors: Jessup, Rebecca L.; Slade, Sian; Roussy, Veronique; Whicker, Susan; Rane, Vinita; Pelly, Janet; Lewis, Virginia; Naccarella, Lucio; Lee, Max Abstract: COVID-19 has had a disproportionate impact on disadvantaged people and migrant communities globally.1 During Australia’s deadly Delta wave, migrants and refugees experienced a mortality rate up to 80 times higher than people born in Australia.2 These populations were slower to take up vaccination,3,4 and more likely to have preexisting health problems that placed them at disproportionally greater risk of deterioration if they contracted the virus.5 In addition, they experienced vulnerabilities related to their ability to trust information provided by figures of authority 6 and how to navigate unfamiliar health systems that present cultural and/or linguistic barriers. Migrant and refugee populations are often underrepresented in health care delivery and leadership roles within mainstream health services, which can compound the mistrust and estrangement from health care service engagement. 2023-12-20T00:00:00Z http://localhost:8080/xmlui/handle/123456789/5898 Title: An analysis of the features of successful written submissions to government inquiries Authors: Delaine, Adam; Ferguson, Megan; Bacon, Rachel; Cullerton, Katherine Abstract: Abstract Objective: Government inquiries present a policy window for advocates to influence policy. Evidence on how to write influential submissions, however, is sparse. We aimed to identify features of successful written submissions to the Parliament of Australia’s Inquiry into Food Pricing and Food Security in Remote Indigenous Communities (Inquiry). Method: A scoping review was conducted to identify influential features of written submissions to government inquiries. A content analysis of a sub-sample of government Inquiry submissions and their recommendations was then coded for influential features. The frequency of submission recommendations incorporated into the final Inquiry report was recorded, as was their link to influential features. Results: Thirty features were identified. Results from 21 submissions indicate that when writing a submission to a government inquiry, advocates should: (1) ensure their submission is clear and concise; (2) convey the authority of both the writer and supporting evidence; and (3) where possible, align submission recommendations with the government agenda. Conclusions: We encourage future research to test the framework of influential features on other inquiry topics and in other countries to increase the reliability of results. Implications for Public Health: This study consolidates and presents a list of features that advocates can consider incorporating when writing a submission to a government inquiry. Key words: public health policy, submissions, policy process, interest groups, advocacy 2024-01-21T00:00:00Z